Protein supplement with Urolithin A for Healthy Subjects

McMaster University, Hamilton, Canada
Healthy Subjects+1 More ConditionsProtein supplement with Urolithin A - DietarySupplement
Eligibility
18 - 30
Male
What conditions do you have?
Select

Study Summary

This trial will investigate if Urolithin A can help prevent muscle decline during illness or injury when people can't use their muscles.

Eligible Conditions
  • Healthy Subjects
  • Muscle Atrophy

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: Day 7, Day 14, Day 28, Day 35; integrated synthesis rates reported for Day 7-14, Day 14-28; Day 28-35

Day 35
Muscle strength (Biodex)
Day 35
Muscle protein fractional synthetic rate
Day 35
Quadriceps muscle size
Day 35
Change in maximal mitochondrial respiration (rate of oxygen flux) and mitochondrial ADP [adenosine diphosphate] sensitivity (Oroboros O2k)

Trial Safety

Phase-Based Safety

1 of 3

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Protein supplement
1 of 2
Protein supplement with Urolithin A
1 of 2

Active Control

Experimental Treatment

24 Total Participants · 2 Treatment Groups

Primary Treatment: Protein supplement with Urolithin A · No Placebo Group · N/A

Protein supplement with Urolithin A
DietarySupplement
Experimental Group · 1 Intervention: Protein supplement with Urolithin A · Intervention Types: DietarySupplement
Protein supplement
DietarySupplement
ActiveComparator Group · 1 Intervention: Protein supplement · Intervention Types: DietarySupplement

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: day 7, day 14, day 28, day 35; integrated synthesis rates reported for day 7-14, day 14-28; day 28-35

Who is running the clinical trial?

McMaster UniversityLead Sponsor
834 Previous Clinical Trials
2,632,761 Total Patients Enrolled
Stuart PhillipsPrincipal InvestigatorMcMaster University

Eligibility Criteria

Age 18 - 30 · Male Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are a male aged between 18 and 30 years.
You are in good health and do not smoke.
Your Body Mass Index is between 20 and 30 kilograms per square meter.

Frequently Asked Questions

Does the research team have any age restrictions for participants?

"This medical trial has set a requirement that all participants must be older than 18 and younger than 30 in order to meet the inclusion criteria." - Anonymous Online Contributor

Unverified Answer

Are new participants being accepted for this research initiative?

"Correct. Data hosted on clinicaltrials.gov reveals that this medical investigation, which was initially uploaded to the site in June 1st 2023, is presently accepting participants. 24 individuals need to be sourced from a single research centre." - Anonymous Online Contributor

Unverified Answer

To what extent are participants engaged in this clinical trial?

"Affirmative. The clinical trial is actively recruiting participants, as displayed on the data hosted at clinicaltrials.gov which was last modified on April 14th 2023. This study requires 24 people to be enrolled from a single site." - Anonymous Online Contributor

Unverified Answer

Who qualifies to partake in this experimental research?

"To qualify for the study, individuals must be within 18 to 30 years of age and have no major health issues. A total of 24 participants are being recruited." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.